Subtopic Deep Dive

ERK Signaling Dynamics in Melanoma
Research Guide

What is ERK Signaling Dynamics in Melanoma?

ERK signaling dynamics in melanoma studies the temporal and spatial regulation of ERK activation through feedback loops, scaffold proteins, and nuclear translocation in melanoma cells using live-cell imaging and kinetic modeling.

ERK, the terminal kinase in the MAPK pathway, exhibits pulsatile activation and subcellular shuttling that dictate proliferative or apoptotic fates in melanoma. Dysregulation arises from BRAF/NRAS mutations prevalent in 50-60% of cases. Over 10 papers from 2006-2023 detail these dynamics, with Burotto et al. (2014) cited 959 times.

Curated Papers

Key Challenges

Why It Matters

ERK dynamics control cell fate decisions, where sustained nuclear ERK drives proliferation and transient cytoplasmic signaling induces apoptosis (Steelman et al., 2011). In melanoma, altered dynamics confer resistance to BRAF/MEK inhibitors, as low MITF/AXL ratios predict early resistance (Müller et al., 2014). Understanding these informs combination therapies targeting feedback loops, improving outcomes in MAPK-mutant melanomas (Guo et al., 2020; Bahar et al., 2023).

Key Research Challenges

Quantifying ERK Pulsatility

Measuring transient ERK phosphorylation bursts requires high-resolution live-cell imaging to distinguish sustained vs. oscillatory signals. Mathematical models struggle with parameter identifiability in noisy data (Burotto et al., 2014). Scaffold proteins like KSR1 complicate kinetic interpretations (Steelman et al., 2011).

Feedback Loop Heterogeneity

Negative feedbacks via DUSP phosphatases vary across melanoma genotypes, leading to divergent responses to inhibitors. Single-cell variability challenges population-level models (Guo et al., 2020). Integrating multi-omics data remains unresolved (Müller et al., 2014).

Nuclear Translocation Modeling

ERK nuclear import/export kinetics depend on phosphorylation states and anchors, but real-time tracking in tumors is limited. Clinical translation from cell lines to patient models faces scalability issues (Bahar et al., 2023).

Essential Papers

ERK/MAPK signalling pathway and tumorigenesis (Review)

Yanjun Guo, Weiwei Pan, Shengbing Liu et al. · 2020 · Experimental and Therapeutic Medicine · 1.4K citations

Mitogen-activated protein kinase (MAPK) cascades are key signalling pathways that regulate a wide variety of cellular processes, including proliferation, differentiation, apoptosis and stress respo...

Signal Transduction in Cancer

Richard Sever, Joan S. Brugge · 2015 · Cold Spring Harbor Perspectives in Medicine · 968 citations

Cancer is driven by genetic and epigenetic alterations that allow cells to overproliferate and escape mechanisms that normally control their survival and migration. Many of these alterations map to...

The <scp>MAPK</scp> pathway across different malignancies: A new perspective

Mauricio Burotto, Victoria L. Chiou, Jean C. Lee et al. · 2014 · Cancer · 959 citations

The mitogen‐activated protein kinase/extracellular signal‐regulated (MAPK/ERK) pathway is activated by upstream genomic events and/or activation of multiple signaling events in which information co...

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Reinhard Dummer, Axel Hauschild, Merlin Guggenheim et al. · 2012 · Annals of Oncology · 716 citations

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

Linda S. Steelman, William H. Chappell, Stephen L. Abrams et al. · 2011 · Aging · 685 citations

Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways is often the result of genetic alterations in critical components in these pathways or upstream activators. Unrest...

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi et al. · 2014 · Nature Communications · 620 citations

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim · 2023 · Signal Transduction and Targeted Therapy · 617 citations

Reading Guide

Foundational Papers

Start with Burotto et al. (2014, 959 citations) for MAPK pathway overview across cancers, then Steelman et al. (2011, 685 citations) for Raf/MEK/ERK feedbacks in proliferation, followed by Carreira et al. (2006, 591 citations) for MITF-ERK proliferation links.

Recent Advances

Guo et al. (2020, 1416 citations) reviews ERK tumorigenesis; Bahar et al. (2023, 617 citations) covers RAS/RAF/MAPK therapy mechanisms.

Core Methods

Live-cell imaging (FRET for ERK activity); kinetic modeling (ODEs for feedbacks); phospho-flow cytometry for population dynamics.

How PapersFlow Helps You Research ERK Signaling Dynamics in Melanoma

Discover & Search

Research Agent uses citationGraph on Burotto et al. (2014) to map 959-cited MAPK papers, then exaSearch for 'ERK nuclear translocation melanoma live imaging' to uncover 50+ dynamics-focused studies. findSimilarPapers expands to scaffold protein roles from Guo et al. (2020).

Analyze & Verify

Analysis Agent applies readPaperContent to Steelman et al. (2011) for Raf/MEK/ERK feedback details, then runPythonAnalysis on extracted kinase time-series data for pulsatility stats using NumPy deconvolution. verifyResponse with CoVe and GRADE scores evidence on dynamic thresholds (A-grade for high-citation claims).

Synthesize & Write

Synthesis Agent detects gaps in feedback modeling via contradiction flagging between Carreira et al. (2006) and recent reviews, generating exportMermaid diagrams of ERK loops. Writing Agent uses latexEditText and latexSyncCitations to draft methods sections, latexCompile for figure-inclusive manuscripts.

Use Cases

"Extract ERK phosphorylation time-courses from melanoma imaging papers and plot oscillation frequencies"

Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas/matplotlib for frequency spectra) → matplotlib plot of pulsatile ERK dynamics.

"Write LaTeX review on ERK scaffold proteins in BRAF-mutant melanoma with citations"

Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → compiled PDF with ERK pathway diagram.

"Find GitHub repos modeling MAPK kinetics from ERK dynamics papers"

Research Agent → searchPapers('ERK melanoma modeling') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → verified kinetic simulation code.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'ERK dynamics melanoma', structures reports with GRADE-graded dynamics claims from Burotto et al. (2014). DeepScan's 7-step chain verifies feedback models from Steelman et al. (2011) with CoVe checkpoints. Theorizer generates hypotheses on pulsatility thresholds from Carreira et al. (2006) and Müller et al. (2014).

Try Doxa for ERK Signaling Dynamics in Melanoma Research

Frequently Asked Questions

What defines ERK signaling dynamics in melanoma?

Temporal patterns of ERK phosphorylation (transient vs. sustained) and localization (cytoplasmic vs. nuclear) controlled by feedbacks and scaffolds determine melanoma cell fate.

What methods study ERK dynamics?

Live-cell FRET/FLIM imaging tracks phosphorylation kinetics; ODE models simulate feedbacks (Burotto et al., 2014). Single-cell RNA-seq reveals heterogeneity (Müller et al., 2014).

What are key papers?

Burotto et al. (2014, 959 citations) overviews MAPK across malignancies; Steelman et al. (2011, 685 citations) details Raf/MEK/ERK feedbacks; Guo et al. (2020, 1416 citations) reviews tumorigenesis roles.

What open problems exist?

Linking single-cell ERK pulsatility to tumor resistance; scalable 3D models of nuclear translocation; genotype-specific feedback predictors (Bahar et al., 2023).